Bristol Myers Squibb - 48 Year Stock Price History | BMY

Historical daily share price chart and data for Bristol Myers Squibb since 1972 adjusted for splits. The latest closing stock price for Bristol Myers Squibb as of September 29, 2020 is 59.90.
  • The all-time high Bristol Myers Squibb stock closing price was 77.94 on October 28, 1999.
  • The Bristol Myers Squibb 52-week high stock price is 68.34, which is 14.1% above the current share price.
  • The Bristol Myers Squibb 52-week low stock price is 45.76, which is 23.6% below the current share price.
  • The average Bristol Myers Squibb stock price for the last 52 weeks is 59.62.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Bristol Myers Squibb Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 60.3669 63.3400 67.4300 46.4000 59.9000 -6.68%
2019 50.1838 52.4300 64.1900 42.7700 64.1900 23.49%
2018 57.7859 61.3100 68.9800 48.7600 51.9800 -15.18%
2017 57.5613 59.4500 65.3500 46.8200 61.2800 4.86%
2016 63.1920 67.0300 76.7700 49.2300 58.4400 -15.05%
2015 64.5237 59.5100 70.7100 57.3000 68.7900 16.53%
2014 52.2089 52.2700 61.3000 46.5900 59.0300 11.06%
2013 43.8476 32.7100 53.8400 32.7100 53.1500 63.09%
2012 33.2952 35.0100 36.1500 30.8100 32.5900 -7.52%
2011 28.9302 26.5800 35.2900 24.9700 35.2400 33.08%
2010 25.6371 25.6300 27.9300 22.4400 26.4800 4.87%
2009 21.7191 23.8800 25.9600 17.5100 25.2500 8.60%
2008 21.6487 26.1300 27.0800 17.2600 23.2500 -12.33%
2007 28.8082 26.3800 32.1400 26.1000 26.5200 0.76%
2006 24.1178 23.2400 26.3200 20.2400 26.3200 14.53%
2005 24.2257 25.4300 26.4800 21.0300 22.9800 -10.30%
2004 25.1550 29.3500 30.6400 22.5000 25.6200 -10.42%
2003 25.2421 24.0300 28.8600 21.1300 28.6000 23.54%
2002 30.9320 50.8500 51.3000 20.5500 23.1500 -54.61%
2001 57.3467 71.5000 71.5000 49.0000 51.0000 -31.03%
2000 58.1863 64.4400 73.9400 43.5000 73.9400 15.19%
1999 68.1165 65.2000 77.9400 57.4400 64.1900 -4.05%
1998 54.3212 47.3150 66.9000 44.9050 66.9000 41.39%
1997 38.1206 26.7750 48.9050 26.7750 47.3150 73.63%
1996 23.0023 21.4075 28.9375 19.9375 27.2500 26.92%
1995 17.2268 14.7500 21.5325 14.5325 21.4700 48.38%
1994 13.9728 14.3750 15.1575 12.6575 14.4700 -0.64%
1993 14.6061 16.5950 16.5950 12.7825 14.5625 -13.70%
1992 17.9620 22.0625 22.1875 15.4375 16.8750 -23.51%
1991 19.8315 16.6575 22.0625 15.3450 22.0625 31.72%
1990 14.7655 14.2500 16.9375 12.7500 16.7500 19.64%
1989 12.4070 11.0950 14.2825 11.0000 14.0000 23.76%
1988 10.6511 10.8125 11.5000 9.6250 11.3125 8.70%
1987 11.9236 10.5463 13.7500 9.1250 10.4075 0.77%
1986 9.4609 8.2188 10.9838 7.5475 10.3275 24.71%
1985 7.3259 6.4063 8.4525 6.2188 8.2813 26.48%
1984 5.7989 5.3913 6.5625 5.2188 6.5475 23.98%
1983 4.8534 4.1875 5.9538 3.9375 5.2813 25.65%
1982 3.7147 3.2969 4.5781 3.1956 4.2031 26.58%
1981 3.2716 3.1875 3.6563 2.8831 3.3206 5.46%
1980 2.5446 2.2738 3.2113 1.9219 3.1488 36.16%
1979 2.1596 2.2263 2.3906 1.9531 2.3125 3.50%
1978 2.1048 2.0863 2.4844 1.7656 2.2344 6.30%
1977 2.0358 2.1250 2.2263 1.8047 2.1019 -2.00%
1976 2.2848 2.1641 2.5859 1.9334 2.1447 -0.35%
1975 1.9405 1.5975 2.3006 1.4725 2.1522 37.38%
1974 1.4518 1.4609 1.7541 0.9881 1.5666 8.11%
1973 1.9110 2.1406 2.2306 1.3750 1.4491 -32.80%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $135.105B $26.145B
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in New York.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $144.684B 15.71
CSL (CSLLY) Australia $96.005B 0.00
Gilead Sciences (GILD) United States $78.797B 11.35
Vertex Pharmaceuticals (VRTX) United States $69.735B 38.91
Regeneron Pharmaceuticals (REGN) United States $60.848B 23.27
Biogen (BIIB) United States $44.650B 7.64
Illumina (ILMN) United States $44.597B 51.86
Seattle Genetics (SGEN) United States $33.148B 0.00
Moderna (MRNA) United States $27.838B 0.00
BeiGene (BGNE) Cayman Islands $25.371B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.832B 10.35
Genmab (GMAB) Denmark $24.169B 15.27
Genmab (GNMSF) Denmark $22.831B 5.26
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $21.243B 0.00
Immunomedics (IMMU) United States $19.767B 0.00
Incyte (INCY) United States $19.762B 0.00
Horizon Therapeutics Public (HZNP) Ireland $16.449B 38.49
Alnylam Pharmaceuticals (ALNY) United States $16.214B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.077B 68.19
BioNTech SE (BNTX) Germany $15.046B 0.00
Exact Sciences (EXAS) United States $14.972B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.143B 102.62
ARGENX SE-ADR (ARGX) Netherlands $12.004B 0.00
QIAGEN (QGEN) Netherlands $11.732B 29.77
Sarepta Therapeutics (SRPT) United States $11.242B 0.00
Guardant Health (GH) United States $10.836B 0.00
Bio-Techne Corp (TECH) United States $9.398B 64.48
Galapagos (GLPG) Belgium $9.252B 33.52
Ascendis Pharma (ASND) Denmark $8.029B 0.00
Repligen (RGEN) United States $7.733B 122.73
Mirati Therapeutics (MRTX) United States $7.438B 0.00
Exelixis (EXEL) United States $7.332B 26.66
SWEDISH ORP BIO (BIOVF) Sweden $7.274B 18.10
MyoKardia (MYOK) United States $7.097B 0.00
Novavax (NVAX) United States $6.813B 0.00
Adaptive Biotechnologies (ADPT) United States $6.568B 0.00
Acceleron Pharma (XLRN) United States $6.528B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.344B 0.00
Momenta Pharmaceuticals (MNTA) United States $6.244B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.873B 181.93
Emergent Biosolutions (EBS) United States $5.485B 21.73
Ultragenyx Pharmaceutical (RARE) United States $4.999B 0.00
Blueprint Medicines (BPMC) United States $4.913B 0.00
Zai Lab (ZLAB) China $4.806B 0.00
Vir Biotechnology (VIR) United States $4.596B 0.00
Arena Pharmaceuticals (ARNA) United States $4.371B 0.00
China Biologic Products (CBPO) China $4.369B 25.93
MorphoSys AG (MOR) Germany $4.168B 54.62
NeoGenomics (NEO) United States $3.993B 1205.33
Legend Biotech (LEGN) United States $3.969B 0.00
Denali Therapeutics (DNLI) United States $3.738B 0.00
Bluebird Bio (BLUE) United States $3.702B 0.00
Amicus Therapeutics (FOLD) United States $3.597B 0.00
Halozyme Therapeutics (HALO) United States $3.553B 0.00
Fate Therapeutics (FATE) United States $3.517B 0.00
Twist Bioscience (TWST) United States $3.351B 0.00
Insmed (INSM) United States $3.346B 0.00
Principia Biopharma (PRNB) United States $3.323B 0.00
Global Blood Therapeutics (GBT) United States $3.291B 0.00
Reata Pharmaceuticals (RETA) United States $3.143B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.814B 0.00
Alkermes (ALKS) Ireland $2.686B 56.30
Sorrento Therapeutics (SRNE) United States $2.457B 0.00
Mesoblast (MESO) Australia $2.281B 0.00
I-Mab (IMAB) China $2.225B 0.00
PHARMA MAR SA (PHMMF) Spain $2.208B 0.00
Forma Therapeutics Holdings (FMTX) United States $2.066B 0.00
Zymeworks (ZYME) Canada $2.052B 0.00
Seres Therapeutics (MCRB) United States $2.043B 0.00
Inovio Pharmaceuticals (INO) United States $2.034B 0.00
Eidos Therapeutics (EIDX) United States $1.946B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.926B 21.57
Akcea Therapeutics (AKCA) United States $1.842B 0.00
Editas Medicine (EDIT) United States $1.815B 0.00
Intra-Cellular Therapies (ITCI) United States $1.772B 0.00
Revance Therapeutics (RVNC) United States $1.713B 0.00
UniQure (QURE) Netherlands $1.618B 0.00
Cytokineticsorporated (CYTK) United States $1.577B 0.00
Amarin (AMRN) Ireland $1.542B 0.00
Ligand Pharmaceuticals (LGND) United States $1.539B 52.04
Viela Bio (VIE) United States $1.449B 0.00
Zealand Pharma (ZEAL) Denmark $1.439B 0.00
Sangamo Therapeutics (SGMO) United States $1.397B 0.00
Beam Therapeutics (BEAM) United States $1.391B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.347B 0.00
Coherus BioSciences (CHRS) United States $1.346B 7.85
Mersana Therapeutics (MRSN) United States $1.341B 0.00
Zealand Pharma (ZLDPF) Denmark $1.339B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.337B 0.00
Intellia Therapeutics (NTLA) United States $1.246B 0.00
Epizyme (EPZM) United States $1.235B 0.00
Arcus Biosciences (RCUS) United States $1.138B 0.00
Compugen (CGEN) Israel $1.102B 0.00
NGM Biopharmaceuticals (NGM) United States $1.081B 0.00
REGENXBIO (RGNX) United States $1.021B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.020B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.020B 0.00
Athenex (ATNX) United States $1.003B 0.00
Alcobra (ARCT) United States $1.001B 0.00
Castle Biosciences (CSTL) United States $0.984B 0.00
Heska (HSKA) United States $0.949B 0.00
Myriad Genetics (MYGN) United States $0.946B 0.00
Retrophin (RTRX) United States $0.920B 0.00
Genetron Holdings (GTH) China $0.903B 0.00
Arvinas (ARVN) United States $0.902B 0.00
Alector (ALEC) United States $0.871B 0.00
Adverum Biotechnologies (ADVM) United States $0.834B 0.00
Morphic Holding (MORF) United States $0.825B 0.00
Vericel (VCEL) United States $0.818B 0.00
Pliant Therapeutics (PLRX) United States $0.799B 0.00
Cellectis S.A (CLLS) France $0.786B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.779B 0.00
NantKwest (NK) United States $0.776B 0.00
Agenus (AGEN) United States $0.743B 0.00
Protagonist Therapeutics (PTGX) United States $0.738B 0.00
MiMedx (MDXG) United States $0.730B 0.00
Codexis (CDXS) United States $0.715B 0.00
Pharming Group (PHGUF) Netherlands $0.704B 16.07
VBI Vaccines (VBIV) United States $0.684B 0.00
Frequency Therapeutics (FREQ) United States $0.669B 0.00
Kadmon Holdings (KDMN) United States $0.643B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Intrexon (PGEN) United States $0.617B 0.00
Northwest Biotherapeutics (NWBO) United States $0.610B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.596B 0.00
Celldex Therapeutics (CLDX) United States $0.586B 0.00
Cara Therapeutics (CARA) United States $0.581B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.580B 0.00
Forte Biosciences (FBRX) United States $0.568B 0.00
Scholar Rock Holding (SRRK) United States $0.543B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.533B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.532B 0.00
Clovis Oncology (CLVS) United States $0.531B 0.00
Geron (GERN) United States $0.531B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.510B 4.46
Anika Therapeutics (ANIK) United States $0.502B 21.95
Albireo Pharma (ALBO) United States $0.493B 0.00
MeiraGTx Holdings (MGTX) United States $0.479B 0.00
Dynavax Technologies (DVAX) United States $0.477B 0.00
IVERIC Bio (ISEE) United States $0.475B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.474B 0.00
Cel-Sci (CVM) United States $0.463B 0.00
Cue Biopharma (CUE) United States $0.447B 0.00
Kala Pharmaceuticals (KALA) United States $0.447B 0.00
MannKind (MNKD) United States $0.442B 0.00
Pfenex (PFNX) United States $0.439B 0.00
Syros Pharmaceuticals (SYRS) United States $0.429B 0.00
Starpharma Holdings (SPHRY) Australia $0.427B 0.00
Avid Bioservices (CDMO) United States $0.425B 0.00
Amryt Pharma (AMYT) United Kingdom $0.412B 0.00
Athersys (ATHX) United States $0.411B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.409B 0.00
Prothena (PRTA) Ireland $0.399B 0.00
Puma Biotechnology (PBYI) United States $0.398B 0.00
UROGEN PHARMA (URGN) United States $0.393B 0.00
AnaptysBio (ANAB) United States $0.387B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.386B 0.00
BioDelivery Sciences (BDSI) United States $0.381B 26.93
PDL BioPharma (PDLI) United States $0.374B 0.00
Trevena (TRVN) United States $0.371B 0.00
Sutro Biopharma (STRO) United States $0.370B 0.00
IBio (IBIO) United States $0.363B 0.00
Kamada (KMDA) Israel $0.362B 17.32
Cellular Biomedicine (CBMG) United States $0.356B 0.00
Merus (MRUS) Netherlands $0.350B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.348B 0.00
Fortress Biotech (FBIO) United States $0.347B 0.00
AC Immune SA (ACIU) Switzerland $0.343B 0.00
ANI Pharmaceuticals (ANIP) United States $0.341B 8.06
WAVE Life Sciences (WVE) Singapore $0.340B 0.00
Precision BioSciences (DTIL) United States $0.339B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.320B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.318B 0.00
CytomX Therapeutics (CTMX) United States $0.309B 0.00
Innate Pharma S.A (IPHA) France $0.304B 0.00
Cardiff Oncology (CRDF) United States $0.283B 0.00
OSMOTICA PHARM (OSMT) United States $0.272B 0.00
Selecta Biosciences (SELB) United States $0.266B 0.00
Prometic Life Sciences (LMNL) Canada $0.260B 0.00
Affimed (AFMD) Germany $0.253B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.253B 0.00
ChromaDex (CDXC) United States $0.251B 0.00
Arbutus Biopharma (ABUS) United States $0.245B 0.00
Cyclerion Therapeutics (CYCN) United States $0.244B 0.00
Pluristem Therapeutics (PSTI) Israel $0.243B 0.00
NextCure (NXTC) United States $0.228B 0.00
TELA Bio (TELA) United States $0.228B 0.00
HOOKIPA Pharma (HOOK) United States $0.217B 0.00
Verastem (VSTM) United States $0.215B 0.00
XOMA (XOMA) United States $0.209B 0.00
GENFIT S.A (GNFT) France $0.208B 0.00
Dyadic (DYAI) United States $0.203B 0.00
Spero Therapeutics (SPRO) United States $0.197B 0.00
Aduro Biotech (ADRO) United States $0.192B 0.00
DBV Technologies S.A (DBVT) France $0.191B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
ADMA Biologics Inc (ADMA) United States $0.187B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.183B 0.00
Biofrontera AG (BFRA) Germany $0.181B 0.00
Liquidia Technologies (LQDA) United States $0.179B 0.00
Kindred Biosciences (KIN) United States $0.177B 0.00
Cerecor (CERC) United States $0.172B 0.00
Theratechnologies (THTX) Canada $0.169B 0.00
CorMedix Inc (CRMD) United States $0.168B 0.00
Eton Pharmaceuticals (ETON) United States $0.168B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.167B 7.80
Five Prime Therapeutics (FPRX) United States $0.167B 0.00
VolitionRX (VNRX) United States $0.159B 0.00
Checkpoint Therapeutics (CKPT) United States $0.157B 0.00
SESEN BIO, INC (SESN) United States $0.157B 0.00
AquaBounty Technologies (AQB) United States $0.153B 0.00
Aptinyx (APTX) United States $0.152B 0.00
Exicure (XCUR) United States $0.151B 0.00
Nicox SA (NICXF) France $0.149B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.145B 0.00
Aytu Bioscience (AYTU) United States $0.144B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.138B 0.00
Celyad SA (CYAD) Belgium $0.130B 0.00
Bellus Health (BLU) Canada $0.129B 0.00
Applied Genetic Technologies (AGTC) United States $0.127B 0.00
VTv Therapeutics (VTVT) United States $0.126B 0.00
Cidara Therapeutics (CDTX) United States $0.124B 0.00
Protalix BioTherapeutics (PLX) Israel $0.119B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.119B 0.00
Strongbridge Biopharma (SBBP) United States $0.117B 0.00
Lumos Pharma (LUMO) United States $0.114B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.112B 0.00
Orgenesis (ORGS) United States $0.110B 5.61
Palatin Technologies (PTN) United States $0.109B 0.00
Antibe Therapeutics (ATBPF) Canada $0.104B 0.00
Enzo Biochem (ENZ) United States $0.102B 0.00
Evogene (EVGN) Israel $0.102B 0.00
Windtree Therapeutics (WINT) United States $0.100B 0.00
Gritstone Oncology (GRTS) United States $0.099B 0.00
Unum Therapeutics (UMRX) United States $0.099B 0.00
PHASEBIO PHARMA (PHAS) United States $0.099B 0.00
Catalyst Biosciences (CBIO) United States $0.097B 0.00
Abeona Therapeutics (ABEO) United States $0.092B 0.00
AIT Therapeutics (XAIR) United States $0.090B 0.00
Oncobiologics (OTLK) United States $0.084B 0.00
Idera Pharmaceuticals (IDRA) United States $0.082B 0.00
Bionano Genomics (BNGO) United States $0.082B 0.00
ARAVIVE, INC (ARAV) United States $0.080B 0.00
Ecology Coatings (ABVC) United States $0.078B 0.00
Edesa Biotech (EDSA) Canada $0.077B 0.00
DiaMedica Therapeutics (DMAC) United States $0.077B 0.00
Synlogic (SYBX) United States $0.070B 0.00
Clearside Biomedical (CLSD) United States $0.070B 0.00
Adocia (ADOCY) France $0.067B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.066B 0.00
Prima BioMed (IMMP) Australia $0.064B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.064B 0.00
TRACON Pharmaceuticals (TCON) United States $0.063B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.061B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.061B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.060B 0.00
Curis (CRIS) United States $0.058B 0.00
Proteostasis Therapeutics (PTI) United States $0.056B 0.00
AmpliPhi Biosciences (ARMP) United States $0.056B 0.00
Appili Therapeutics (APLIF) Canada $0.053B 0.00
Soligenix (SNGX) United States $0.053B 0.00
Cocrystal Pharma (COCP) United States $0.050B 0.00
Novogen (KZIA) Australia $0.049B 0.00
CollPlant Holdings (CLGN) Israel $0.047B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
Stealth BioTherapeutics (MITO) United States $0.046B 66.00
Signal Genetics (MGEN) United States $0.046B 0.00
Organovo Holdings (ONVO) United States $0.045B 0.00
Genetic Technologies (GENE) Australia $0.045B 0.00
Happiness Biotech Group (HAPP) China $0.044B 0.00
AnPac Bio-Medical Science (ANPC) China $0.043B 0.00
IMMURON (IMRN) Australia $0.040B 0.00
Pulmatrix (PULM) United States $0.039B 0.00
Vaccinex (VCNX) United States $0.035B 0.00
ATyr Pharma (LIFE) United States $0.035B 0.00
Apricus Biosciences (SEEL) United States $0.035B 0.00
Chanticleer Holdings (SONN) United States $0.035B 0.00
Prana Biotechnology (ATHE) Australia $0.030B 0.00
OvaScience (MLND) United States $0.029B 0.00
Acorda Therapeutics (ACOR) United States $0.029B 0.00
BioCardia (BCDA) United States $0.028B 0.00
Cleveland BioLabs (CBLI) United States $0.027B 0.00
Advaxis (ADXS) United States $0.026B 0.00
Alimera Sciences (ALIM) United States $0.026B 0.00
Celsion (CLSN) United States $0.024B 0.00
Aptevo Therapeutics (APVO) United States $0.024B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.023B 0.00
Cesca Therapeutics (THMO) United States $0.020B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.020B 0.00
Spherix (AIKI) United States $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
MYOS RENS Technology (MYOS) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
BioPharmX (TMBR) United States $0.011B 0.00
Neuralstem (SNCA) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
GeoVax Labs (GOVX) United States $0.002B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00